Lidocaine Hcl
Brand names: Dermacinrx Lidogel, Glydo, Lidocaine Hcl, Lidocaine Hcl Viscous, Xylocaine
At a glance
- Medicare prescriptions, 2024
- 171,820
- Medicare drug cost
- $3.1M
- Average cost per prescription
- $18.16
- Clinicians who prescribed it
- 7,794
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
No FDA prescription label was found for this drug name.
Who prescribes it
- Family Medicine 20.8%
- Nurse Practitioners 19.3%
- Internal Medicine 16.4%
- Radiation Oncology 9.8%
- Physician Assistants 7.1%
- Hematology & Oncology 3.0%
- Dentists (general) 2.8%
- Geriatric Medicine 2.7%
- Gastroenterology 2.6%
- ENT (Otolaryngology) 1.9%
- Urology 1.7%
- Oral & Maxillofacial Surgeons 1.6%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
Trend, 2019–2024
Medicare prescriptions fell 4% from 2019 to 2024.
Biggest change by state since 2019
- Kentucky +17%
- Connecticut +12%
- Arkansas +10%
- New York +9%
- Florida +9%
- Puerto Rico (smallest change) −27%
- Colorado (smallest change) −21%
From CMS’s yearly state and national Part D summaries, which count every prescriber, including those CMS leaves out of its per-clinician data (fewer than 11 prescriptions). That is why these totals are higher than the count at the top of this page. Prescriptions include refills.
What it looks like
Pills from 1 maker on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
The Procter & Gamble Manufacturing Company
| Strength | Looks like | Imprint |
|---|---|---|
| 4 g / 1 g menthol | white liquid | |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
Drug makers reported $1,365 in payments to clinicians that named this drug in 2025 (meals, speaking, consulting and similar).
- Sagent Pharmaceuticals $1,365
Source: CMS Open Payments, general payments (not research), program year 2025. A payment is not evidence of wrongdoing. Payments by doctor
Recalls and shortages
Not on the FDA drug shortage list.
1 recall since 2020
- Nov 2020 · Mpm Medical LLC · Class I
Microbial Contamination of Non-Sterile Drug Product. The product was found to be contaminated with the bacteria Burkholderia cepecia.
Recalls usually affect specific lots from one maker, not every version of a drug. Class I is the most serious; most drug recalls are Class II. FDA recalls (opens in a new tab)
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.